Literature DB >> 30224551

Heterogeneity in FoxP3- and GARP/LAP-Expressing T Regulatory Cells in an HLA Class II Transgenic Murine Model of Necrotizing Soft Tissue Infections by Group A Streptococcus.

Suba Nookala1, Santhosh Mukundan2, Alexander Fife2, Jeyashree Alagarsamy2, Malak Kotb2.   

Abstract

Invasive group A streptococcus (GAS) infections include necrotizing soft tissue infections (NSTI) and streptococcal toxic shock syndrome (STSS). We have previously shown that host HLA class II allelic variations determine the risk for necrotizing fasciitis (NF), a dominant subgroup of NSTI, and STSS by modulating responses to GAS superantigens (SAgs). SAgs are pivotal mediators of uncontrolled T-cell activation, triggering a proinflammatory cytokine storm in the host. FoxP3-expressing CD4+ CD25+ T regulatory cells (Tregs) comprise phenotypically and functionally heterogeneous subsets with a profound ability to suppress inflammatory responses. Specifically, activated Tregs, which express glycoprotein A repetitions predominant (GARP) and display latent transforming growth factor β1 (TGF-β1) complexes (latency-associated peptide [LAP]), exhibit strong immunosuppressive functions. The significance of Tregs that may participate in suppressing inflammatory responses during NSTI is unknown. Here, we phenotypically characterized FoxP3/GARP/LAP-expressing Tregs in GAS-infected or SAg (SmeZ)-stimulated splenocytes from transgenic (tg) mice expressing human HLA-II DRB1*15 (DR15 allele associated with nonsevere NF/STSS-protective responses) or DRB1*0402/DQB1*0302 (DR4/DQ8 alleles associated with neutral risk for combined NF/STSS). We demonstrated both in vivo and in vitro that the neutral-risk allele upregulates expression of CD4+ CD25+ activated effector T cells, with a significantly lower frequency of Foxp3+/GARP+ LAP- but higher frequency of Foxp3- LAP+ Tregs than seen with the protective allele. Additional in vitro studies revealed that the presentation of SmeZ by the neutral-risk allele significantly increases proliferation and expression of effector cytokines gamma interferon (IFN-γ) and interleukin-2 (IL-2) and upregulates CD4+ CD25+ T cell receptors (TCRs) carrying specific Vβ 11 chain (TCRVβ11+) T cells and Th1 transcription factor Tbx21 mRNA levels. Our data suggest that neutral-risk alleles may drive Th1 differentiation while attenuating the induction of Tregs associated with suppressive function.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  FoxP3/GARP/LAP; HLA-II; T regulatory cells; group A streptococcus

Mesh:

Substances:

Year:  2018        PMID: 30224551      PMCID: PMC6246916          DOI: 10.1128/IAI.00432-18

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Regulatory T cells: roles of T cell receptor for their development and function.

Authors:  Naganari Ohkura; Shimon Sakaguchi
Journal:  Semin Immunopathol       Date:  2010-02-24       Impact factor: 9.623

3.  Inducing and expanding regulatory T cell populations by foreign antigen.

Authors:  Karsten Kretschmer; Irina Apostolou; Daniel Hawiger; Khashayarsha Khazaie; Michel C Nussenzweig; Harald von Boehmer
Journal:  Nat Immunol       Date:  2005-10-23       Impact factor: 25.606

4.  Cutting edge: human latency-associated peptide+ T cells: a novel regulatory T cell subset.

Authors:  Roopali Gandhi; Mauricio F Farez; Yue Wang; Deneen Kozoriz; Francisco J Quintana; Howard L Weiner
Journal:  J Immunol       Date:  2010-04-05       Impact factor: 5.422

5.  Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.

Authors:  M C Fantini; C Becker; I Tubbe; A Nikolaev; H A Lehr; P Galle; M F Neurath
Journal:  Gut       Date:  2005-09-14       Impact factor: 23.059

6.  Modulation of expression of superantigens by human transferrin and lactoferrin: a novel mechanism in host-Streptococcus interactions.

Authors:  Rita G Kansal; Ramy K Aziz; Malak Kotb
Journal:  J Infect Dis       Date:  2005-05-11       Impact factor: 5.226

7.  HLA transgenic mice provide evidence for a direct and dominant role of HLA class II variation in modulating the severity of streptococcal sepsis.

Authors:  Mohammed M Nooh; Nagala El-Gengehi; Rita Kansal; Chella S David; Malak Kotb
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

8.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

9.  Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.

Authors:  K Nakamura; A Kitani; W Strober
Journal:  J Exp Med       Date:  2001-09-03       Impact factor: 14.307

10.  Bacterial superantigens promote acute nasopharyngeal infection by Streptococcus pyogenes in a human MHC Class II-dependent manner.

Authors:  Katherine J Kasper; Joseph J Zeppa; Adrienne T Wakabayashi; Stacey X Xu; Delfina M Mazzuca; Ian Welch; Miren L Baroja; Malak Kotb; Ewa Cairns; P Patrick Cleary; S M Mansour Haeryfar; John K McCormick
Journal:  PLoS Pathog       Date:  2014-05-29       Impact factor: 6.823

View more
  2 in total

1.  Metallothionein 3-Zinc Axis Suppresses Caspase-11 Inflammasome Activation and Impairs Antibacterial Immunity.

Authors:  Debabrata Chowdhury; Jason C Gardner; Abhijit Satpati; Suba Nookala; Santhosh Mukundan; Aleksey Porollo; Julio A Landero Figueroa; Kavitha Subramanian Vignesh
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

2.  HLA-II Alleles Influence Physical and Behavioral Responses to a Whey Allergen in a Transgenic Mouse Model of Cow's Milk Allergy.

Authors:  Danielle L Germundson; Suba Nookala; Nicholas A Smith; Yassmine Warda; Kumi Nagamoto-Combs
Journal:  Front Allergy       Date:  2022-04-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.